Skip to content

13F-HR filed by Trails Edge Capital Partners, LP

Trails Edge Capital Partners, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 16:23:29 UTC, with 38 holding rows worth $695,902,449.

Accession
0002077247-26-000005
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 38 entries on the cover page, a total value of $695,902,449 stated on the cover page (in dollars after the unit check, H1), rows summing to $695,902,449 with VALUE read as dollars as filed, 13F file number 028-26566. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LB PHARMACEUTICALS INC50180M108COMMON STOCK1,149,240$44,107,831dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM667,000$40,020,000dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK1,573,220$37,301,046dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share2,495,660$34,265,412dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR1,063,234$32,205,358dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock2,227,917$31,881,492dollars as filed
DESIGN THERAPEUTICS INC25056L103COM2,500,000$31,425,000dollars as filed
CYTOKINETICS INC23282W605COM NEW470,000$30,977,700dollars as filed
FIRST TRACKS BIOTHERAPEUTICS337185102ORD SHS *A*814,000$28,848,160dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW941,689$28,005,830dollars as filed
TANGO THERAPEUTICS INC87583X109COM1,100,000$27,445,000dollars as filed
NEUROGENE INC64135M105COMMON STOCK964,885$26,843,100dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW765,000$24,793,650dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK1,500,000$22,995,000dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock1,693,694$22,729,374dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK1,000,000$21,870,000dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock1,680,000$19,656,000dollars as filed
INHIBIKASE THERAPEUTICS INC45719W205COMMON STOCK9,110,112$18,721,280dollars as filed
INHIBRX BIOSCIENCES INC45720N103COM170,000$17,013,600dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock400,000$14,876,000dollars as filed
CAMP4 THERAPEUTICS CORP13463J101COM3,625,576$14,647,327dollars as filed
ALTIMMUNE INC02155H200COM NEW4,230,000$12,097,800dollars as filed
OPUS GENETICS INC67577R102COMMON STOCK2,411,657$11,672,420dollars as filed
KAILERA THERAPEUTICS INC482931102COMMON STOCK942,953$10,768,523dollars as filed
SOL-GEL TECHNOLOGIES LTDM8694L137SHS NEW139,445$10,357,974dollars as filed
INVENTIVA SA46124U107ADS2,657,997$9,808,009dollars as filed
ENTRADA THERAPEUTICS INC COM29384C108Stock1,428,440$9,070,594dollars as filed
AURA BIOSCIENCES INC05153U107COMMON STOCK1,443,333$9,064,131dollars as filed
Research Alliance Corp Iii Ord Shs Cl AG75226103Common Stock822,500$8,907,676dollars as filed
X4 PHARMACEUTICALS INC98420X202COMMON STOCK2,571,478$7,457,287dollars as filed
CENTURY THERAPEUTICS INC15673T100COM4,134,969$7,070,797dollars as filed
PROMIS NEUROSCIENCES INC74346M505COM SHS557,103$6,044,568dollars as filed
RESEARCH ALLIANCE CORP IVG75228109CL A ORD SHS500,000$6,000,000dollars as filed
IMAGENEBIO INC45175G207CMN1,094,045$5,010,726dollars as filed
MINERVA NEUROSCIENCES INC603380205COM NEW1,419,000$4,753,650dollars as filed
TCGX ACQUISITION CORPG8708J109COM250,000$3,127,500dollars as filed
VTV THERAPEUTICS INC918385204CL A NEW76,989$2,374,341dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A619,557$1,688,293dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002077247-26-000005this filing2026-11-16